META-1i

N/A

Report date: 2024/11/04 14:58:52
NMEFirst In Class

Base Information

Drug NameMETA-1i
Drug Alias NameMETA-01META-001META-1iMETA-1i-AID
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicMultiple Sclerosis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMeta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMeta Pharmaceuticals IncXtalPi Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicMultiple Sclerosis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A